Key FDA Official Dr. Vinete Prasad Departs After Three Months Amid Drug Controversy
CNBC TelevisionAugust 7, 20251 min2,746 views
1 connectionsΒ·2 entities in this videoβDeparture of FDA's Chief Medical and Science Officer
- π¨ Dr. Vinete Prasad, the FDA's chief medical and science officer, has departed his position after only three months.
- π‘ Dr. Prasad led the center responsible for regulating vaccines, gene therapies, and other biologic drugs.
Controversy Over Alvdus Drug Handling
- β οΈ His tenure was marked by criticism regarding the FDA's handling of the SEPTA therapeutics duchane musculardrophe drug Alvdus.
- π The FDA initially halted shipments of Alvdus following the deaths of some recipients.
- β However, the suspension was removed earlier this week.
Official Statement and Future Plans
- π¬ In a statement, Health and Human Services indicated Dr. Prasad did not want to be a distraction to the FDA's work.
- π¨βπ©βπ§βπ¦ He has decided to return to California to spend more time with his family.
- π The department thanked him for his service and the important reforms he achieved during his time at the FDA.
Upcoming Interview
- π€ The program will feature an interview with FDA Commissioner Dr. Marty McCary in the next hour.
- π£οΈ They will discuss Dr. Prasad's departure and other FDA initiatives.
Knowledge graph2 entities Β· 1 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
2 entities
Chapters1 moments
Key Moments
Transcript5 segments
Full Transcript
Topics10 themes
Whatβs Discussed
FDADr. Vinete PrasadSEPTA therapeuticsAlvdusDrug RegulationVaccine RegulationGene TherapyBiologic DrugsDepartment of Health and Human ServicesDr. Marty McCary
Smart Objects2 Β· 1 links
ProductΒ· 1
CompanyΒ· 1